The half-billion-dollar idea
While at MIT, alumnus Todd Zion developed an insulin product that ultimately drew the attention of a pharmaceutical giant.
While at MIT, alumnus Todd Zion developed an insulin product that ultimately drew the attention of a pharmaceutical giant.
Simulations reveal that the formation of some glassy materials is like the setting of a bowl of gelatin.
MIT alumni’s startup provides rapid, cost-effective microRNA profiling, which is beneficial for diagnosing diseases.
Indian teen Tuhin Bagi uses MIT OpenCourseWare to enhance his studies and set his sights on future endeavors.
MIT team finds a more economical way to create valuable building blocks for pharmaceuticals
MIT researchers improve efficiency of quantum-dot photovoltaic system by adding a forest of nanowires.
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
MIT leads in seven engineering disciplines and three business fields, says U.S. News & World Report.
New approaches to drug delivery offer hope for new, more targeted treatments.
New surface coating for glass could eliminate image distortion caused by condensation and also prevent frost buildup.
New analysis points the way to optimizing efficiency of an integrated system for harvesting sunlight to make storable fuel.
Study of several dozen compounds based on a fungal chemical shows potent anti-tumor activity.
Yeast research takes a step toward production of alternatives to gasoline.
New room-temperature process could lead to less expensive solar cells and other electronic devices.
Enlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.